Nausea is a very common and distressing problem. Some medications that treat nausea carry a higher risk for arrhythmias, like Torsades de Pointes, and sudden cardiac death. Is ondansetron safe for use in patients on hemodialysis?
This week, we will discuss non-steroidal mineralocorticoid antagonist in the multiverse of cardiovascular-kidney-metabolic. What FINEHEART pooled analysis would add to what we already learned from FIDELIO-DKD trial?
This week is time antibody mediated rejection treatment in kidney transplant. A new molecule targeting CD38, on the horizon, safely tested in a phase 2 trial
This week, we will discuss the ongoing saga of blood pressure targets in patients with hypertension. This time its ESPRIT (Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing Risk of Vascular Events) making a case for case for intensive BP control in most hypertensive individuals, including those with a history of diabetes and stroke.
Fascinating observational study on hyponatraemia correction rates this week, catch-up here.
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) November 17, 2023
✳️10 tweet #NephJC catch-up ✳️
The challenge has been declared to the concept that rate of hyponatraemia correction is as vital as nephrologists have been telling you - to know if you agree, you need to know the studies the challenge is based upon🧵👇 pic.twitter.com/S5XVH9QqRb
Check out the beautiful Visual Abstract for this week’s NephJC by Arjun Mohan.
